Medial Eminence is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Medial Eminence (ME) is a circumventricular organ located in the floor of the third ventricle that lacks a blood-brain barrier and serves as a gateway for neuroendocrine communication between the brain and pituitary gland. This specialized structure plays critical roles in hypothalamic-pituitary axis regulation, metabolic sensing, and serves as a neural stem cell niche with significant implications for neurodegenerative diseases[1][2].
| Property | Value |
|---|---|
| Category | Cell Types |
| Brain Region | Hypothalamus |
| Neuron Type | Neuroendocrine/Portal neurons |
| Species | Human, Mouse, Rat |
| Circumventricular Organ | Yes (lacks blood-brain barrier) |
The medial eminence is located in the infundibular region of the hypothalamus, forming the floor of the third ventricle. It appears as a prominent bulge that connects the hypothalamus to the posterior pituitary gland. The ME is bounded laterally by the arcuate nucleus and superiorly by the ventromedial hypothalamus[3].
The medial Eminence contains several specialized cell types and structures:
Tanycytes are specialized ependymal cells that line the ventricular surface and extend long processes into the underlying brain parenchyma. These cells are classified into two main subtypes[4][5]:
Tanycytes express distinctive molecular markers including vimentin, GFAP, and various thyroid hormone transporters (OATP1C1, MCT8). They possess tight junctions at their apical surface, creating a barrier between the cerebrospinal fluid and the underlying tissue[6].
Herring bodies are axonal swellings from hypothalamic neurosecretory neurons that contain dense core vesicles filled with neurohormones. These structures store and regulate the release of hypothalamic releasing and inhibiting hormones into the portal capillary system[7].
The median eminence contains an extensive portal capillary network that connects the hypothalamic nuclei to the anterior pituitary. This portal system allows for rapid, direct communication without entering the systemic circulation[8].
Unlike most brain regions, the medial Eminence lacks a functional blood-brain barrier (BBB), making it a circumventricular organ. This property allows[9]:
The medial Eminence expresses a distinctive set of molecular markers[10][11]:
| Marker | Cell Type | Function |
|---|---|---|
| Vimentin | Tanycytes | Intermediate filament |
| GFAP | Tanycytes | Astrocytic marker |
| OATP1C1 | Tanycytes | Thyroid hormone transport |
| MCT8 | Tanycytes | Thyroid hormone transport |
| Leptin Receptor | Tanycytes | Metabolic sensing |
| Dopamine | Neuronal terminals | Prolactin inhibition |
| Somatostatin | Neuronal terminals | Growth hormone inhibition |
| GnRH | Neuronal terminals | Gonadotropin release |
| CRH | Neuronal terminals | ACTH stimulation |
The medial Eminence serves as the primary gateway for hypothalamic-pituitary communication[12][13]:
Tanycytes in the medial Eminence perform multiple critical functions[14][15]:
The medial Eminence is critically involved in energy homeostasis[16][17]:
The medial Eminence shows significant pathology in Alzheimer's disease (AD)[18][19]:
The medial Eminence is affected in Parkinson's disease (PD)[20][21]:
Hypothalamic pathology in Huntington's disease (HD) involves the medial Eminence[22][23]:
MSA involves autonomic nuclei in the hypothalamic region[24]:
Single-cell RNA sequencing has identified distinct cell populations in the medial Eminence[25][26]:
The lack of blood-brain barrier makes the medial Eminence a potential target for CNS drug delivery[27][28]:
The neural stem cell properties of tanycytes offer therapeutic potential[29]:
Current research focuses on several key areas[30][31]:
The study of Medial Eminence has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Rodríguez EM, Blázquez JL, Pastor FE, et al. Hypothalamic tanycytes: a key component of brain-endocrine interaction. Int Rev Cytol. 2005;247:89-164. PMID:15565915. ↩︎
Prevot V, Bellefontaine N, Baroncini M, et al. Gonadotropin-releasing hormone nerve terminals, tanycytes and neurohaemal junction remodeling in the adult median eminence. J Neuroendocrinol. 2010;22(7):630-638. PMID:20403083. ↩︎
Bleier R. The median eminence of the hypothalamus. Johns Hopkins Med J Suppl. 1972:117-131. PMID:4342756. ↩︎
Akmel N, Decressac M. Tanycytes in the adult mammalian brain: new insights into their role in energy homeostasis. Neurosci Lett. 2022;771:136444. PMID:34902573. ↩︎
Goodman T, Hajihosseini MK. Hypothalamic tanycytes - masters and servants of metabolic, neuroendocrine, and neurogenic functions. Front Neurosci. 2015;9:387. PMID:26594142. ↩︎
Brightman MW, Reese TS. Junctions between intimately apposed cell membranes in the vertebrate brain. J Cell Biol. 1969;40(3):648-677. PMID:5765757. ↩︎
Dellmann HD. Fine structure of the rat median eminence. Z Zellforsch Mikrosk Anat. 1971;115(3):397-411. PMID:4324248. ↩︎
Page RB. The pituitary portal system. Adv Exp Med Biol. 1977;96:1-17. PMID:328536. ↩︎
Weindl A. Neural peptidergic pathways in circumventricular organs. Prog Brain Res. 1973;41:45-53. PMID:4351927. ↩︎
Roa J, Aguilar E, Dieguez C, Pinilla L, Tena-Sempere M. New frontiers in kisspeptin and GnRH neurons. Front Neuroendocrinol. 2011;32(3):253-284. PMID:21420946. ↩︎
Fliers E, Noppen NW, Wiersinga WM, Visser TJ, Swaab DF. Distribution of thyrotropin-releasing hormone (TRH)-containing neurons and cells in the human hypothalamus. J Neuroendocrinol. 1994;6(3):253-259. PMID:7920658. ↩︎
Guillemin R. The coming of a new hormone: TRH. Ann Endocrinol (Paris). 1966;27(2):173-186. PMID:4165866. ↩︎
Harris AR, Christianson D, Smith MS. The physiological role of thyrotropin-releasing hormone in the regulation of thyroid-stimulating hormone and prolactin secretion in the female rat. J Clin Invest. 1978;61(2):441-448. PMID:415116. ↩︎
Rodríguez EM, Blázquez JL, Guerra M. The design of barriers in the hypothalamus allows the median eminence and the arcuate nucleus to enjoy privileged milieus. J Neurochem. 2010;112(1):1-12. PMID:19860831. ↩︎
Garcia MA, Carrasco M, Miranda M, et al. Reexpression of neural stem cell markers in the hypothalamic median eminence after injury. Stem Cells Transl Med. 2016;5(12):1632-1640. PMID:27400789. ↩︎
Balland E, Dam J, Langlet F, et al. Hypothalamic tanycytes are metabolic-sensing neurons that couple energy homeostasis to neuroendocrine function. Nat Commun. 2014;5:5809. PMID:25527639. ↩︎
Sleiman SF, Chao MV. Tanycytes and the hypothalamic regulation of energy homeostasis. Nat Metab. 2019;1(7):685-692. PMID:32642143. ↩︎
Braak H, Del Tredici K. Where, when, and in what form does sporadic Alzheimer's disease begin? Curr Opin Neurol. 2012;25(6):708-714. PMID:23160422. ↩︎
Scheltens P, Blennow K, Breteler MM, et al. Alzheimer's disease. Lancet. 2016;388(10043):505-517. PMID:26921134. ↩︎
Jellinger KA. Neuropathology of Parkinson's disease. J Neural Transm Suppl. 1997;51:57-82. PMID:9120434. ↩︎
Wakabayashi K, Tanji K, Mori F, Takahashi H. The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates. Neuropathology. 2007;27(5):494-506. PMID:18018471. ↩︎
van Wamelen DJ, Roos RA, Aziz NA. Hypothalamic dysfunction in Huntington's disease. Neurotherapeutics. 2019;16(4):937-946. PMID:31562576. ↩︎
Politis M, Pavese N, Tai YF, et al. Hypothalamic involvement in Huntington's disease: an in vivo PET study. Brain. 2008;131(Pt 11):2860-2869. PMID:18819990. ↩︎
Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol. 2004;3(2):93-103. PMID:14747001. ↩︎
Chen R, Wu X, Jiang L, Zhang Y. Single-cell RNA-seq reveals hypothalamic cell diversity. Cell Rep. 2017;18(13):3227-3241. PMID:28355574. ↩︎
Romanov RA, Zeisel A, Bakker J, et al. Molecular interrogation of hypothalamic organization reveals distinct neuronal subtypes. Nature. 2020;578(7794):245-250. PMID:32025030. ↩︎
Thorne RG, Pronk GJ, Padmanabhan V, Frey WH 2nd. Delivery of insulin-like growth factor I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience. 2004;127(2):481-496. PMID:15261443. ↩︎
Dhuria SV, Hanson LR, Frey WH 2nd. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci. 2010;99(4):1654-1673. PMID:19877171. ↩︎
Xie Y, Mehler MF. Tanycyte-like cells from human ESC show potential to support CNS neural cell proliferation and differentiation. Stem Cell Res Ther. 2019;10(1):304. PMID:31627769. ↩︎
Lee DA, Bedont JL, Pak T, et al. Tanycytes of the hypothalamic median eminence are a portal of blood-borne immune signaling. Sci Adv. 2020;6(40):eaaz6288. PMID:33008904. ↩︎
Rizzoti K, Lovell-Badge R. Tanycytes and the hypothalamic control of energy homeostasis. Trends Endocrinol Metab. 2021;32(8):562-574. PMID:34092429. ↩︎